Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule-Reference-Cited by-同舟云学术

Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule

Published:2014-02-12 Issue:4 Volume:57 Page:1557-1572
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Modi Gyan¹,Antonio Tamara²,Reith Maarten²³,Dutta Aloke¹

Affiliation:

1. Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States

2. Department of Psychiatry, New York University, New York, New York 10016, United States

3. Department of Biochemistry and Molecular Pharmacology, New York University, New York, New York 10016, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm401883v

Reference56 articles.

1. Staging of brain pathology related to sporadic Parkinson’s disease

2. The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

3. Wooten, G. F.InMovement Disorders: Neurologic Principles and Practice;Watts, R. L.; Koller, W. C., Eds.McGraw-Hill:New York, 1997; pp153–160.

4. Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation, synthesis and medicinal chemistry of biphenyl analogs – A review;Results in Chemistry;2023-12

2. D-685 Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson’s Disease Animal Models;ACS Chemical Neuroscience;2023-02-07

3. Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants;Protein Science;2022-11-16

4. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

5. A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders;Current Drug Targets;2022-07